Physician

Paul W Lenkowski, M.D.PH.D.

According to 2025 Medicare claims, Paul Lenkowski, M.D.PH.D. (NPI: 1497964886) practices otolaryngology in the Roanoke, VA market, with the plurality of this provider's patient population coming from Roanoke City, VA. This provider's primary affiliated billing organization is ROANOKE VALLEY ENT & ALLERGY PC (NPI: 1174005417; TIN: 831700209) and primary practice location at 24018-3410.

Lenkowski's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 832 traditional Medicare patients, billed 20,097 HCPCS/CPT codes, and received $879,319 in Medicare payments. The top billing code was 31231 (Diagnostic exam of nasal passages using an endoscope). Part D data shows 2,309 prescription claims across 717 beneficiaries totaling $58,694 in drug costs, led by Ipratropium Bromide (Ipratropium Bromide). DME data shows 24 claims. Open Payments data shows 133 records totaling $54,761. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $207,131 to $879,319. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $55,235 and ending at $58,694. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $3,984 to $2,041.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	977	4,751	$207,131
2016	788	5,421	$182,298
2017	1,073	8,202	$267,264
2018	869	5,864	$225,589
2019	793	6,713	$448,003
2020	779	8,002	$418,315
2021	890	8,466	$432,934
2022	819	10,699	$578,657
2023	798	16,073	$819,429
2024	832	20,097	$879,319

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	409	1,336	$55,235
2016	328	1,025	$36,386
2017	435	1,410	$47,110
2018	412	1,247	$35,768
2019	473	1,543	$37,313
2020	527	1,871	$52,874
2021	583	1,995	$55,220
2022	566	1,810	$58,879
2023	557	1,734	$53,911
2024	717	2,309	$58,694

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	22	$1,329
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	12	$404
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	20	$806
2024	N/R	24	$959

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
31231	Diagnostic exam of nasal passages using an endoscope	383	541	$117
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	322	322	$111
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	290	350	$60
70220	X-ray of paranasal sinus, minimum of 3 views	376	399	$25
95165	Professional service for preparation and provision of 1 or more antigens	149	5,005	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ipratropium Bromide	Ipratropium Bromide	364	18,251	$12,440
Azelastine Hcl	Azelastine Hcl	219	12,127	$6,672
Epinephrine	Epinephrine	35	512	$6,070
Fluticasone Propionate	Fluticasone Propionate	388	21,869	$3,736
Doxycycline Monohydrate	Doxycycline Monohydrate	267	2,812	$2,699

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A7031	Face mask interface, replacement for full face mask, each	N	N/R	12	$858
A7038	Filter, disposable, used with positive airway pressure device	N	N/R	12	$101

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	133	$54,761	Stryker Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Paul W. Lenkowski, M.D.PH.D.?

Tedicare shows public-source Medicare data for Paul W. Lenkowski, M.D.PH.D. (NPI 1497964886), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Paul W. Lenkowski, M.D.PH.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Paul W. Lenkowski, M.D.PH.D.?

Paul W. Lenkowski, M.D.PH.D. is linked to ROANOKE VALLEY ENT & ALLERGY PC (billing NPI 1174005417) in the available physician profile data.

Does Paul W. Lenkowski, M.D.PH.D. have Open Payments data?

Paul W. Lenkowski, M.D.PH.D. has 133 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.